Stem cells derived from a human placenta hold the key to unlocking a myriad of potentials in regenerative medicine and are the focus of X-Prize and Singularity University founder Peter Diamandis’ new endeavor. Called Celularity, the startup is a spinout from Celgene, a global biopharmaceutical company creating gene therapies. Celularity in the hopes of using stem cells found in the human placenta to quickly regenerate tissue and organs needed to treat cancer and other diseases. Read more>>